WHO IS TYLER LEBARON MSc, PhD Founder and executive director of the Molecular Hydrogen Institute (MHI), and one of the world’s leading authorities on molecular hydrogen science. With a background in biochemistry, physiology, and mitochondrial biology, Tyler has dedicated his career to researching how hydrogen impacts oxidative stress, inflammation, cellular signaling, and longevity. His work includes collaborations with top Japanese research labs, contributions to over 3,000 peer-reviewed publications in the field, and leadership in advancing hydrogen therapy as a credible, evidence-based tool for health optimization. Today, Tyler is recognized internationally as a key figure in molecular medicine, educating clinicians, scientists, and biohackers on how hydrogen can improve cellular resilience, recovery, and long-term human performance. This time will be exploring how molecular hydrogen impacts deeper longevity pathways—stem cell resilience, inflammation balance, mitochondrial repair, and gene expression. Tyler explains why hydrogen supports recovery without blocking gains, how it activates NRF2 and other longevity pathways, and how dosing really works across tablets, bottles, and inhalation. You’ll also hear where hydrogen research is heading globally, including medical device approvals in Asia and major clinical trials. This final episode reveals why hydrogen is poised to become a cornerstone of personalized longevity medicine.